These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Adrenocortical carcinoma with feminization: "in vivo" and "in vitro" study (author's transl)].
    Author: Pugeat M, Merchak A, Revol A, Tourniaire J.
    Journal: Ann Endocrinol (Paris); 1980; 41(2):107-18. PubMed ID: 7469380.
    Abstract:
    A 31 year-old man with adrenocortical carcinoma is presented. Clinically he had a recidiving gynecomastia. The levels ddhydro-épi-androstérone (D.H.E.A.) and his ester Sulfate (D.H.E.A.S.), delta-4-androsténédione (A), estrone (Et), estradiol (E2) in urines, serum and tumor were very high. The cortisol production rate was in normal values. The serum levels or cortisol, D.H.E.A., D.H.E.A.S. and A were not increased by A.C.T.H. injection. In vitro, steroidogenesis in the tumor cells was not influenced by A.C.T.H. or prostaglandin E1, but stimulated by dibutyryl cyclic 3'5' adenosine monophosphate. Unresponsiveness of A.C.T.H. was related to an alteration of cells membranes receptors.
    [Abstract] [Full Text] [Related] [New Search]